FMOC-THR(GALNAC(AC)3-Α-D)-OH
FMOC-THR(GALNAC(AC)3-Α-D)-OH 物理性質
- 融点 :
- 178-183°C
- 沸点 :
- 857.1±65.0 °C(Predicted)
- 比重(密度) :
- 1.38±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- -20°C
- 外見 :
- Solid
- 酸解離定数(Pka):
- 3.32±0.10(Predicted)
- 色:
- White to off-white
- 光学活性 (optical activity):
- [α]22/D +55.0°, c = 1% in chloroform
- InChIKey:
- OXLCJWGAUPPZQJ-ZNHCDWFHSA-N
安全性情報
WGK Germany |
3 |
|
|
HSコード |
2932 99 00 |
|
|
FMOC-THR(GALNAC(AC)3-Α-D)-OH 価格
もっと(6)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01BCS4025798 |
Fmoc-Thr(GalNAc(Ac)3-α-D)-OH
Fmoc-Thr(GalNAc(Ac)3-alpha-D)-OH |
116783-35-8 |
25mg |
¥103000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01BCS4025798 |
Fmoc-Thr(GalNAc(Ac)3-α-D)-OH
Fmoc-Thr(GalNAc(Ac)3-alpha-D)-OH |
116783-35-8 |
100mg |
¥410000 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
772437 |
97%
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH 97% |
116783-35-8 |
25mg |
¥47900 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
772437 |
97%
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH 97% |
116783-35-8 |
100mg |
¥116000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01BCS4025798 |
Fmoc-Thr(GalNAc(Ac)3-α-D)-OH
Fmoc-Thr(GalNAc(Ac)3-alpha-D)-OH |
116783-35-8 |
250mg |
¥819000 |
2024-03-01 |
購入 |
FMOC-THR(GALNAC(AC)3-Α-D)-OH 化学特性,用途語,生産方法
化学的特性
White to off-white solid
使用
Fluorescently labeled glycopeptides containing GalNAcα1-O-Ser/Thr residues provide valuable immunology probes for the development of cancer vaccines.
FMOC-THR(GALNAC(AC)3-Α-D)-OH 上流と下流の製品情報
原材料
準備製品
FMOC-THR(GALNAC(AC)3-Α-D)-OH 生産企業
Global( 116)Suppliers
FMOC-THR(GALNAC(AC)3-Α-D)-OH スペクトルデータ(1HNMR)
116783-35-8(FMOC-THR(GALNAC(AC)3-Α-D)-OH)キーワード:
- 116783-35-8
- N-FMOC-O-(3,4,6,-TRI-O-ACETYL-2-ACETAMIDO-2-DEOXY-Α-D-GALACTOPYRANOSYL)-L-THREONINE
- Fmoc-L-Ser(α-D-GalNAc(Ac)3)-OH
- Fmoc-L-Thr(GalNAc(Ac)3-α-D)-OH
- Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-threonine≥ 97% (HPLC)
- Fmoc-Thr(AcAcNH-α-Gal)-OH Novabiochem
- N-FMOC-O-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-threonine
- Fmoc-L-Thr(α-D-GalNAc(Ac)3)-OH
- N-Fmoc-O-beta-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine
- Fmoc-L-Thr(TnAc4)-OH, N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine
- Fmoc-Thr(GalNAc(Ac)3-a-D)-OH
- FMOC-L-THR(TNAC4)-OH
- FMOC-L-THR(ALPHA-D-GALNAC(AC)3)-OH
- FMOC-THREONINE(GALNAC(AC)3-ALPHA-D)-OH
- FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH
- FMOC-THR(AC3ACNH-ALPHA-GAL)-OH
- GALNAC L-THREONINE
- Fmoc-L-Thr(TnAc4)-OH,N-alpha-(9-fluorenylmethyloxycarbonyl)-O-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyr
- N-alpha-(9-Fluoroenyloxycarbonyl)-o-(2-acetamido-2deoxy-3,4,6-tri-o-acetyl-alpha-d-galactopyranosyl)-l-threonine
- N-FMoc-O-[3,4,6-tri-O-acetyl-2-(acetylaMino)-2-deoxy-α-D-galactopyranosyl]-L-threonine
- N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-galactopyranosyl)-L-thereonine
- FMoc-Thr(2-acetaMido-3,4,6,-tri-O-acetyl-
2-deoxy-α-D-galactopyranosyl)-OH
- FMoc-Thr-(Ac3AcNH-α-Gal)-OH
- N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylaMino)-2-deoxy-α-D-galactopyranosyl]-L-threonine
- N-a-FMoc-O-b-(2-acetaMido-2-deoxy-3,4,6-tri-O-acetyl-a-D-galactopyranosyl)-L-threonine
- FMoc-Thr(α-D-GalNAc(Ac)3)-OH
- N-ALPHA-FMOC-O-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- N-ALPHA-FMOC-O-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-(2-ACETAMIDO-2DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- GalNAc-Thr
- FMOC-THR(GALNAC(AC)3-Α-D)-OH